Europe BGM and CGM Market was valued at USD 3.2 Billion in 2022 and is projected to reach USD 6.5 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
Europe's BGM and CGM Market: Types and Industry Requirements
The European market for Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) devices has experienced significant growth, driven by the increasing prevalence of diabetes and advancements in monitoring technologies. Understanding the types of devices available and the specific requirements from industries is crucial for stakeholders aiming to navigate this evolving landscape effectively.
Market Overview
As of 2022, the global BGM and CGM market was valued at approximately USD 16,790 million, with projections indicating a rise to USD 37,610 million by 2029, reflecting a Compound Annual Growth Rate (CAGR) of 12.2% during the forecast period. Europe holds a substantial portion of this market, accounting for around 30% of the global share, underscoring its significance in the diabetes care sector.
Types of Monitoring Devices
Blood Glucose Monitoring (BGM) Devices: These devices provide intermittent testing using portable glucometers, allowing users to measure blood sugar levels at specific times. BGM devices are widely used due to their affordability and ease of use.
Continuous Glucose Monitoring (CGM) Systems: CGM devices offer real-time monitoring by measuring glucose levels continuously throughout the day and night. They provide comprehensive data, enabling better glycemic control and timely interventions.
Currently, BGM devices occupy a market share of approximately 60%. However, the demand for CGM systems is increasing rapidly due to their advanced features and the growing emphasis on proactive diabetes management.
Industry Requirements and Trends
The healthcare industry in Europe has specific requirements and trends influencing the adoption and development of BGM and CGM devices:
Accuracy and Reliability: Healthcare providers and patients demand devices that deliver precise and consistent readings to ensure effective diabetes management.
Integration with Digital Platforms: There's a growing need for devices that can seamlessly integrate with mobile applications and electronic health records, facilitating data sharing and remote monitoring.
User-Friendly Design: Devices with intuitive interfaces and minimal discomfort during use are preferred to enhance patient compliance and satisfaction.
Cost-Effectiveness: Affordable pricing models are essential to ensure accessibility, especially in publicly funded healthcare systems prevalent across Europe.
Regulatory Compliance: Adherence to stringent European medical device regulations is mandatory for market approval and acceptance.
Personal Experience and Insights
In my experience working within the European healthcare sector, I've observed a marked shift towards the adoption of CGM systems. Healthcare professionals appreciate the continuous data provided by CGMs, which aids in making informed treatment decisions. Patients, too, have expressed increased satisfaction due to the reduced need for finger-prick tests and the ability to monitor their glucose levels in real-time.
Moreover, industries involved in manufacturing these devices are increasingly focusing on incorporating advanced technologies such as artificial intelligence to predict glucose trends and provide personalized alerts. This aligns with the broader move towards personalized medicine, aiming to tailor healthcare solutions to individual patient needs.
Challenges and Opportunities
Despite the positive trends, challenges remain. The high cost of CGM systems can be a barrier for widespread adoption, particularly in regions with budget constraints. Additionally, ensuring data privacy and security as devices become more connected is a growing concern.
However, these challenges present opportunities for innovation. Developing cost-effective solutions and enhancing cybersecurity measures can significantly boost market growth. Collaborations between tech companies and healthcare providers are emerging to address these issues, aiming to deliver robust and secure monitoring systems.
Conclusion
The European BGM and CGM market is poised for substantial growth, driven by technological advancements and a heightened focus on effective diabetes management. By understanding the types of devices available and aligning with industry requirements, stakeholders can effectively contribute to improving patient outcomes and advancing the diabetes care landscape in Europe.
Get an In-Depth Research Analysis of the Europe BGM and CGM Market Size And Forecast [2025-2032]
Â
Roche
Lifescan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
Sinocare
Yicheng
Yuwell
Acon
Dexcom
Medtronic
Senseonics Holdings
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe BGM and CGM Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe BGM and CGM Market
Blood Glucose Meters (BGMs)
Test Strips
Lancets
Insulin Delivery Devices
Individuals with Diabetes
Clinics and Healthcare Facilities
Research Institutions
Online Stores
Pharmacies/Drug Stores
Hospitals
Specialty Diabetes Stores
Children (Under 18)
Adults (18-64)
Seniors (65 and Above)
Traditional Monitoring
Smart Technology Enabled Devices
Continuous Glucose Monitoring Technology
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ BGM and CGM Market Research Analysis
1. Introduction of the Europe BGM and CGM Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe BGM and CGM Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe BGM and CGM Market, By Type
6. Europe BGM and CGM Market, By Application
7. Europe BGM and CGM Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe BGM and CGM Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/